Catalyst Wire Dossier Catalyst Wire Dossier

Conatumumab

conatumumab
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Conatumumab, covering 2013-06-24 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) [Phase 2]

See pricing